Cholera Vaccines Market Size

Cholera Vaccines Market Size

Cholera Vaccines Market size was valued at USD 89.4 million in 2023 and is estimated to grow at 8.4% CAGR from 2024 to 2032, due to the growing global burden of cholera outbreak, especially in areas with insufficient water and sanitation infrastructure.

To get key market trends

  Download Free Sample

For instance, according to the World Health Organization (WHO), there are 1.4 to 4.3 million cholera cases and up to 143,000 deaths annually, with a disproportionate burden in Africa and South Asia. This significant impact emphasized the urgent need for effective vaccination programs and prevention strategies, thereby expanding the market growth.
 

Additionally, growing awareness and initiatives by governments and international organizations to implement mass vaccination campaigns has fostered the market demand. Furthermore, the rising travel to endemic areas also boosts demand for cholera vaccines, as does the development of more accessible and affordable travel vaccine formulations, which enhance immunization efforts and market penetration.
 

Cholera vaccines are biological preparations used to provide active immunity against cholera, an acute diarrheal disease caused by the bacterium Vibrio cholerae. These vaccines are designed to stimulate the body's immune response to prevent the onset of the disease upon exposure to the pathogen.